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Introduction 
 
Addressing loneliness has been part of the public health agenda in countries like the 
UK and Canada since before the COVID-19 pandemic. Linked to numerous physical and 
mental health conditions, adverse effects of loneliness have been observed in educational, 
workplace and wider community settings. Loneliness is also linked to increases in health and 
social care usage1 due to increased mortality, blood pressure, depression, and anxiety, and 
decreased mobility and quality of life.2,3  
Loneliness is a subjective, unwelcome feeling of lack or loss of companionship that 
occurs when there is a mismatch between the quantity and quality of social relationships that a 
person has, and those that that person wants.4,5 Though often associated with isolation, 
loneliness is distinct in that it is a feeling, while isolation is an objective measure of the number 
and quality of contacts that one has6. Thus, it is possible to be lonely while surrounded by 
others, or to have very few social contacts but not feel lonely. Loneliness can also perpetuate 
itself, disrupting social interaction and integration and reducing one’s healthy relationships.  
The need to address loneliness has become all the more urgent since the onset of 
COVID-19, as individuals and organisations have sought to maintain social connection amidst 
restrictions on physical interaction. Social care and public health agencies have distributed 
digital tablets, created online forums, and hosted virtual events in attempts to help keep people 
connected. To help inform efforts to address this need, we present this systematic review of 
evaluations of interventions designed to tackle loneliness.  
Specifically, we focus on interventions known as social prescribing. Concurrent with 
increased awareness about loneliness and its threat to public health, practitioners, policy 
makers, and researchers around the world have been calling for a fundamental change in 
healthcare systems to implement person-centred, holistic care. This social model of health has 
  
been adopted in various forms in Canada7, the  UK8, and the US9, and social prescribing 
programmes are a part of it. 
The example of the United Kingdom (UK) can help illustrate the believed linkages 
between loneliness and social prescribing. In 2018, the UK Government published the 
Loneliness Strategy. Since then it has devoted significant resources to combatting loneliness 
and improving individual and community wellbeing, including engaging with numerous 
charities, to demonstrate its commitment to tackle loneliness and promote social connections.10 
In 2019, the UK Government launched Universal Personalised Care (UPC), a system designed 
around 6 key pillars meant to give individuals choice and control over their mental and physical 
health. UPC was intended to help the UK health system enhance value for money and improve 
overall health and wellbeing, including through the reduction of loneliness.11  
The fourth UPC pillar is centred on social prescribing. Social prescribing programmes 
employ link workers (also called community connectors, community navigators, and/or village 
agents) to guide participants to co-develop personalised solutions for their own health. As an 
asset-based, collaborative approach, social prescribing programmes are designed to identify 
needs and resources, promote and develop individual and community capacities, and 
ameliorate symptoms and consequences of poor health.12 With the UPC launch, the UK 
Government committed to reaching more than 900,000 people via social prescribing by 
2023/24. Through this  commitment it was intended to also reduce loneliness and improve 
public health.13 
In the UK, there are four sectors associated with social prescribing interventions. First, 
some general practitioner (GP) practices within the health sector are actively engaging link 
workers to accept referrals and work individually with people and families. Second, 
organisations in the voluntary and community service (VCS) sector individually with people 
and families and supply an array of innovative and engaging activities for them to access for 
  
support and connection. This sector both employs link workers directly, and also supplies many 
of the services that other link workers recommend.  
Third, social care services offer complementary support to vulnerable and elderly 
people and families by developing the market for social prescribing, by commissioning and 
funding community activities, and by supplying social prescribing via local authorities and/or 
councils. And finally, Departments of Public Health provide social prescribing services as they 
seek to enhance the health of the population as a whole, providing evidence on the position and 
quality of public health and filling gaps in the availability of services. One person might 
therefore encounter social prescribing via any one of these sectors, or via an integrated care 
system that combines these sectors to offer a holistic approach to care and wellbeing. 
The variety of ways in which social prescribing (SP) can be offered means there can 
also be a variety of aims and goals between programmes. Many SP services run out of GPs, for 
example, are interested in how SP can improve health and reduce the burden on the health care 
system; these programmes are overseen by the National Health Service in the UK. Those SP 
services run by local councils might be overseen by Departments of Public Health, Social 
Services, or Public Safety; their key goals could be improved public health or security. SP 
programmes implemented by the VCS tend to be focused on individual wellbeing. 
The diversity of goals of SP programmes, combined with the recent surge in social 
prescribing in the UK and person-centred care around the world, raises questions regarding the 
effectiveness and impact of these models on mental and physical wellbeing in general, and on 
loneliness in particular. As a collaborative effort between public, private, and third sector 
organizations, social prescribing is well-suited to provide person-centred healthcare and 
improve public health outcomes. Yet we need more information about social prescribing 
outcomes if we are to understand the extent to which they affect loneliness.14,15,11 This 
systematic review therefore focuses on interventions designed to reduce loneliness, detailing 
  
methods used to differentiate and define individuals’ health conditions and needs, as well as 
the impact of the social prescribing interventions employed to reach lonely individuals.  
We analyse research into social prescribing schemes in the UK and internationally over 
two decades. In contrast to previous reviews16,17, we follow 2019 NHS England and Drinkwater 
et al recommendations13,8 to evaluate outcomes of social prescribing-type programmes by 
assessing the impact of a programme at three levels: the person; the health and social care 
systems; and the community. These three levels of measurement capture a range of potential 
impacts and help us understand the effects of social prescribing as an approach to engage and 
empower individuals and communities to co-design health plans, reduce loneliness, and 
promote public health. 
As we detail below, our work yields evidence on the use of social prescribing initiatives 
to address loneliness in the UK, but does not end up including evaluations of initiatives from 
other countries, despite the fact that we did not restrict our search geographically. We offer two 
potential explanations for this outcome. First, the use of social prescribing to address loneliness 
is still a novel concept; social prescribing programmes are often evaluated in terms of other 
aims and the UK is the only context that measures outcomes in terms of loneliness.  
Second, we focus on the term ‘social prescribing’ for our search to isolate an increase 
in the literature on social prescribing across the globe (see Box 1). As a result, our findings do 
not include research on other similar programmes, such as Local Area Coordination, 
Community Navigation, or Village Agents, unless they also include the ‘social prescribing’ 
moniker. To the extent that this alterative terminology is more commonly used in other 
contexts, these programmes highlight parts of the world or health systems excluded from our 
search. 
Methods 
 
  
We followed the Preferred Reporting Items for Systematic Reviews and Meta-Analyses 
(PRISMA) guidelines and Pettigrew and Roberts advice in conducting our review.18,19 Our 
protocol has not been registered on the PROSPERO register of systematic reviews, but is 
available from the authors upon request.  
Design and Sample 
Research Strategy  
We conducted a comprehensive search in social science and public health repositories 
to identify existing studies on the effect of social prescribing on loneliness. Through 
EBSCOHost, we searched nine bibliographic databases (CINAHL Complete, eBook 
Collection, E-Journals, MEDLINE with Full Text, Open Dissertations, PsycARTICLES, 
PsycINFO), as well as the UK National Institute for Health and Care Excellence (NICE) and 
Web of Science Core Collection, for research published in the English language from 1 January 
2000 to 30 November 2019. EBSCOHost and Web of Science Core Collection include many 
peer-reviewed, high-quality scholarly journals published worldwide (including open access 
journals) as well as conference proceedings and books. NICE provides access to numerous 
social science and medical journals such as The BMJ, as well as links to work published by 
think tanks, non-profit organizations, community health groups, and the government.20 We 
searched for combinations of social prescribing, evaluation, and potential impact 
(Supplementary Box 1).  
As mentioned above, the UK commonly uses the term ‘social prescribing’ to 
characterise an asset-based model of service delivery. Models such as Local Area Co-
ordinators, community navigators, or Village Agents are also based on the social model of 
health to connect people to their communities and universal services, often through voluntary 
sector services. We chose to focus on the term ‘social prescribing’ to recognise and investigate 
the rise of literature and programming across the globe using this term.   
  
 
Box 1.  Search strategy used in the systematic review of social prescribing 
programmes on loneliness 
(social prescri* AND lonel*) AND (interven* OR evaluat* OR program*) 
(social prescri* AND connect*) AND (interven* OR evaluat* OR program*) 
(social prescri* AND well-being) AND (interven* OR evaluat* OR program*) 
(social prescri* AND wellbeing) AND (interven* OR evaluat* OR program*) 
(social prescri* AND well being) AND (interven* OR evaluat* OR program*) 
(social prescri* AND isolat*) AND (interven* OR evaluat* OR program*) 
 
Inclusion Criteria and Data Collection  
Two researchers screened the identified abstracts. Studies were eligible for inclusion if 
they included a programme or initiative designed to offer person-centred care. We included 
both peer-reviewed and grey literature reporting studies evaluating the impact of one or more 
interventions on one or more level of analysis: the person, the health and care system, or the 
community. When doubt or disagreement occurred on whether an article met the inclusion 
criteria, the article was moved to the next stage of screening. After initial screening, we 
appraised the studies to determine whether the programmes were designed to address loneliness 
either as a sole characteristic or as one of several. We excluded systematic reviews, studies that 
did not include an evaluation of an intervention, and instructional materials that gave advice 
on how to conduct social prescribing programmes.  
Data Synthesis  
The researchers independently assessed the full text of potentially eligible studies and 
extracted details of the studies into a database. The data collected were: country and area of the 
programme or intervention; aim of the programme; type of programme (signposting, light, 
medium, or holistic)21; whether programme was implemented via general practitioners (GPs), 
  
the voluntary sector, social care workers, or an integrated care system; study time frame and 
data collection period; study type and sampling method; description of study population (age, 
gender, location, health characteristics); sample size; analytical method; evaluation design 
(randomised, control group present, pre/post testing); and outcome/impact reported on the 
person, the health and social care system, and/or the community. The outcome of interest for 
the review was loneliness. 
Results  
 
Study Identification  
 
Our search yielded 22199 references, of which 4415 were unique entries. 
Supplementary Table 1 illustrates our process. We excluded 4212 articles after screening titles 
and abstracts. Of the 203 references that potentially met the inclusion criteria, 152 were 
excluded for different reasons (Figure 1). Left with 51 studies, we excluded 42 because they 
were not designed to address loneliness. This process left 9 articles for review. Of these, 3 were 
designed to address loneliness as a sole characteristic, and 6 were designed to address 
loneliness in addition to social isolation, well-being and/or connectedness. Study results are 
highly heterogeneous, due to variability in sampling methods and the definition of loneliness. 
In view of this heterogeneity and the absence of confidence intervals, we do not attempt meta-
analysis. 
 
  
  
Figure 1. PRISMA flow diagram of the systematic review of social prescribing programmes 
designed to address loneliness across the globe  
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
  
Records identified through 
database searching 
(n = 22177) 
Full-text articles assessed 
for eligibility 
(n = 203) 
Records excluded 
(n = 4212) 
Records screened 
(n = 4415) 
Duplicates removed 
(n =17784) 
Additional records identified 
through other sources 
(n = 22) 
Studies included for full 
article review 
(n = 51) 
Studies included in the 
review 
(n = 9) 
Full-text articles excluded  
(n =  152) 
 
8 social prescribing programme 
without evaluation results 
17 systematic reviews 
43 general article on social prescribing  
65 general articles on one or more 
topics (loneliness, connectedness, 
well-being, social isolation); 
19 not related (typically about   
medical prescription) 
 
  
Study characteristics 
 
Two publications are peer-reviewed articles and 7 are study reports. The 9 articles are 
based on 9 social prescribing initiatives conducted in the United Kingdom from 2014-2019. 
Eight of the studies include a total of 12359 study participants, plus at least 9000 in the ninth 
study  that does not report exact numbers. Three of the studies include individuals aged 16 
years or older22,23, one has participants aged 29-8515, 1 has participants aged 36-4024, 1 has 
participants aged either under 30 or over 60, and 1 has participants aged over 65.25 Two of the 
studies do not specify participants’ ages.26,27  
Six studies employ a pre/post design 15,22–26 and 3 report case studies with evidence 
taken at one point in time.27–29 None of the studies consider a control group. Three studies 
conduct surveys only,22,23,25 2 conduct interviews only,28,29 and 4 mix the two methods.15,24,26,27 
Five studies are conducted with social prescribing recipients only22–25,29 while 4 also present 
information gathered from link workers, volunteers, and GPs who deliver the program.15,26–28 
Four studies either do not distinguish between loneliness, connectedness, and isolation, 
or use the terms interchangeably.25,23,24,28 Five studies define and justify how they measure 
loneliness.30 Of these, 2 use the 8-item UCLA scale,5,15,29 1 uses the 3-item UCLA scale,22,31 1 
uses the Adult Social Care and Public Health Outcome Framework,25,32 and 1 uses the 
Hawthorne (2000) Friendship Scale.24,33 Four either do not report how they assess loneliness26–
28
 or do not report how their assessments were designed or chosen.23  
 
 
 
 
 
 
  
Table 1. Systematic review of social prescribing programmes designed to implement loneliness across the globe, during 2000-2019 period       
  
SP programme 
name 
Location 
Aim of SP initiative 
Sample characteristics 
SP programme participant 
characteristics 
Date of SP program 
Evaluation research design, method 
Measures of loneliness Impact 
Programme 
name:  
Dudley 
Community and 
Voluntary 
Services23  
 
Location: 
Dudley, UK 
Aim: Connecting people, helping them 
find purpose in their lives. Reducing 
patient demand on GP and A&E. 
 
N= 2720 
 
Age: 16 +; 60% aged 64+, 37% aged 24 – 
63, with remaining 3% between 16-23.  
 
Participants: Patients that frequently 
attend their GP practice, are in top 2% at 
high risk of admission and any vulnerable 
person in need of non-clinical support as 
identified by their GP. Isolation was the 
highest reason for referral.  
Date: September 2014 – August 2018 
 
Design and method:  
Pre/post and case studies;  
surveys. 
 
Measurement: Isolation/Loneliness 
used interchangeably. Six indicators 
of social contact, no justification. 
 
Person: Number of people feeling lonely and without enough contact reduced by 46 % (87-46). 
Number of people feeling un-lonely and with enough contact increased by 39 % (97-135). 
 
System: GP visits: Of the 43 GP practices, 6 months post-programme 8 practices had an 
increase of 63 additional consultations in total, 34 had a decrease of 2,125 in total, and 1 had no 
change. Most health care providers reported the key benefit of SP to be reduction in participants’ 
isolation and loneliness.  
A&E: 14% reduction in participants’ attendance after 6 months,17% reduction after 12 months. 
Inpatient Admissions 14% reduction after 6 months, 15% reduction after 12 months.  
 
Community: Not assessed.  
Programme 
name: 
Connecting 
Communities 
Programme22 
 
Location: 
30 locations 
across the UK 
Aim: To re-connect lonely or socially 
isolated people to their communities and 
provide emotional and practical support. 
To offer person-centred support to build 
self-confidence and resilience and help 
people forge social connections.  
 
N=over 9000 (no exact number).  
 
Age: 51% aged under 70. 82 % of the 
sample was classed as being lonely 
(UCLA scale) at the start of the program. 
 
Participants: Statutory health and care 
services such as the NHS (22%) and local 
authorities (19%), and others such as 
family and friends, private organisations, 
and self-referral. 
Date: May 2017 – December 2018 
 
Design and Design and method: 
Pre/post; 
surveys.  
 
Measurement: 3-item UCLA 
loneliness scale.  
Person: 69% less lonely, 27% no change; 4% more lonely. Participants under 60 years old had 
more improvement in loneliness compared to those over 60. Greater impact on participants 
identified as being in a life transition (health issues, mobility limitations, new child, recent 
bereavement, divorce/ separation, retirement, children moving out) than on those not 
experiencing transition.  
System: Not assessed. 
Community: Not assessed. 
  
Programme 
name:  
Social Cure15 
 
Location: 
English East 
Midlands, UK 
Aim: Determine which social factors are 
central to understanding social 
prescribing, how social prescribing is 
experienced across participants and those 
who deliver the program, provide 
evidence base for impact of social 
prescribing and the consequences for 
patient’s health care use.  
 
N= Study 1: 19 participants; 7 GPs 
referring participants; 3 health coaches 
and 6 link workers working with 
participants. N= Study 2: 630 
participants at a 4-month follow-up after 
initial referral assessment. 
 
Age: 29–85 years (average Age: 60.4).  
 
Participants: Referred by GP or self-
referral. 37% (n=7) multiple/complex 
needs including loneliness. 53% (n=10) 
weight loss + multiple needs including 
loneliness. Social Cure received 1483 
referrals and supported approximately 
650 patients. 
Date: November 2017–February 
2019 
 
Design and method:  
Pre/post;  
Study 1: semi-structured interviews; 
Study 2: longitudinal survey. 
Considers participants’ gender, age, 
relationship status, employment status 
and education levels and pre and post- 
programme levels of loneliness, 
community belonging and health care 
usage to test the pathway between the 
programme designed to address 
loneliness and health care usage 
outcomes.  
 
 
Measurement: 8-item 
UCLA Loneliness 
Scale (ULS-8).  
 
Person: Loneliness and social isolation are key threats to public health and can be addressed 
through social prescribing. Interviews revealed that being a part of a group (family, community, 
volunteering group) and feeling that one belongs to a community helps people feel less lonely. 
Participants report that having a positive relationship with link workers has helped them build 
self-confidence, which in turn has helped them address their experiences of loneliness. Group 
membership alone is not directly and significantly related to primary case usage. Sense of 
community belonging and should be considered when examining this pathway.  
 
System: GP visits: GPs, health coaches, and link workers recognise the limitations of the 
‘traditional medical model’, and express concerns over addressing loneliness with medical 
provisions. GPs view social prescribing as best model to address loneliness and reduce its 
negative health impacts.  
 
Community: Primarily focuses on understanding how community resources can be used to 
reduce loneliness and health care usage, and less so on impact of the programme on community.  
Programme 
name:  
Museum on 
Prescription29 
 
Location: 
London and 
Kent, UK 
Aim: To support the wellbeing of socially 
isolated and lonely older people by 
assessing impact of participation in 12 
Museum on Prescription programmes.  
 
N=20 
 
Age: 65-94 
 
Participants:  
Selected from a pool of 155 individuals 
who self-identified as lonely or socially 
isolated. 
Date: Not specified. 
 
Design and method:  
Case Study; 
Interviews, theory building using 
grounded theory analysis and 
inductive approach. 
 
Measurement: R-UCLA Loneliness 
Scale (Russell et al., 1980).  
Person: Participants report feeling less lonely, more able to develop meaningful connections and 
friendships, greater confidence, more mental stimulation and more feelings of happiness. 
 
System: Not directly assessed. Theoretical discussion supports prevention-based initiatives. 
Offers framework for considering individual characteristics and life experiences when 
developing community-based later-life social interventions. 
 
Community: Not directly assessed. Theoretical discussion suggests that opportunities to 
develop new connections, engage in new experiences, and become more socially engaged could 
inspire participants to make a positive change in their own communities.  
  
Programme 
name:  
Not reported26 
 
Location: 
Unnamed local 
authority area, 
UK 
Aim: Pilot was developed with an aim to 
discover sustainable and strategic 
approach to commissioning services that 
supported primary care objectives. The 
aim of the evaluation was to examine the 
changes in the health care use and 
changes in participant’s well-being.  
 
N1= 108 (consists of  
42 opted to participate in a "pump-
priming" component  
62 opted out of “pump-priming” portion 
N2=280 participants from pilot only 
assessed for their well-being.  
 
Age: not specified.  
 
Participants: Referred by GP. 
 
Date: Not specified. 
 
Design and method:  
Pre/post; 
Surveys and interviews with 44 carer, 
commissioners, providers 
 
Measurement: Not provided.  
Person: Quotations evidence a reduction in loneliness and social isolation.  
 
System: A&E: 20% reduction in number of visits in 12-month post-participation period. 
Participants in pump-primed service experience greater reduction in this service demand 
compared to those who opted out – an average difference of 0.22 attendances per participant. 
Inpatient admissions: 21% reduction in the number of admissions in 12-month post-
participation period. Participants in pump-primed service experience greater reduction in 
inpatient service demand compared to those who opted out – an average difference of 0.10 
attendances per participant. Outpatient appointments: 21% reduction in the number of 
admissions in 12-month post-participation period. Participants in pump-primed service 
experience greater reduction in outpatient service demand compared to those who opted out – an 
average difference of 0.31 attendances per participant. 
 
Community: Reports that unspecified number of participants became volunteers engaged in 
wider voluntary and community activity once pilot concluded. 
Programme 
name: 
Doncaster 
Social 
Prescribing25 
 
Location: 
Doncaster, UK 
 
Aim: To help with the effects of long 
term physical and mental health 
conditions. 
 
N=1054  
 
Age: more than half of the sample 60 
aged and over, around a quarter over 80, 
and the rest were 30 years and under.  
 
Participants: Referred by GP, 
community nurses and pharmacists. 
Date: 08-2015—06-2016 
 
Design and method: 254 participants 
completed an intake questionnaire  
and either 3 or 6-month follow-up 
(n=215). Pre and post-programme 
comparisons.  
 
Measurement: Adult Social Care and 
Public Health Outcome Framework 
(ASCOF/PHOF) is used to assess 
levels of social isolation and 
loneliness (used interchangeably). 
Person: Participants feel less isolated or alone post-participation, “feeling like they had someone 
they could turn to”. No direct evidence or discussion on the loneliness measure that was 
administered. 19% increase in people having “enough social contact”.  
  
System: GP visits: 68% report reduction in GP appointments; 15% report increase; 17% no 
change. A&E: 7% report reduction in attendance; 1% report increase; 92% no change. Inpatient 
Admissions: 9% report reduction in stays; 3% increase; 90% no change. Social Care: 3% report 
reduction in contacts with social worker; 97% report no change (3% of sample reported having a 
contact with social services 3 months prior to start of the program).  
 
Community: A non-specified number of volunteers have found employment since being 
involved the project. 88% report greater awareness of the services and support available.  
  
Programme 
name: Age 
UK’s Cascade 
Training27 
 
Location: 
Across England, 
UK 
Aim: To evaluate the effectiveness of the 
consultancy support, training, and 
training packs. To engage older people in 
activities to improve health and well-
being, reduce the demand for health and 
social care, and help delivery 
organisations to train volunteers to 
engage hard-to-reach, older people. 
 
N= 5368 older people;  
1382 volunteers;  
75 delivery organisations  
 
Age: Not reported.  
 
Participants: Not reported. 
Date: 2013-2015 
 
Design and method: interviews, 
surveys, focus groups, documentary 
analysis, follow-up with 
organisations' data collection teams.  
 
Measurement: Not reported. 
Person: Service delivery staff report positive impact of social prescribing on loneliness, 
recommended that training manuals include measures to address loneliness and social isolation. 
95% of staff report ability to support more older people as a direct result of the program. 58% of 
volunteers report positive impact on their own mental health and well-being.  
 
System: Positive impact on care home services, improving residents’ quality of life.  
 
Community: Delivery organisations report expanding services and creating new activities due to 
program. Programme brought together housing associations, sheltered housing and care home 
staff, health care providers, faith-based organisations, and local charities, which has a positive 
impact on community engagement. Participants report interest in helping others and sharing 
information, thereby expanding community capacity to respond to challenges.  
Programme 
name: Social 
Prescribing 
Pilot28  
 
Location: 
Rotherham, UK 
Aim: Assist GPs to meet the non-clinical 
needs of patients with complex long-term 
conditions. 
 
N=559; n=451 (6 months post-referral) 
       n=108 (12 months post-referral).  
 
Age: 87 % aged 60-69; 75% 70 -79; 47% 
80-89; 10 % aged 90 and over.  
 
Participants: GP-led Integrated Case 
Management Teams referring patients via 
GPs to Community and Voluntary 
Services 
 
Date: 09-2012—04-2014 
 
Design and method:  
Case studies; 
Interviews with participants (17) and 
with individuals delivering service 
(10).  
 
Measurement: none.  
Person: Participants report feeling like they belong more to a community and that they have 
enjoyed more social contact, with researchers drawing conclusions on reduction in loneliness and 
isolation.  
 
System: GP visits: not reported. A&E: 38% of participants report a reduction in attendance 12 
months post-referral, 25% report reduction 6 months post-referral. Inpatient Admissions: 40% 
reduction 12 months post-referral, 24% 6 months post-referral. Outpatient admissions: 47% 
reduction 12 months post-referral, 30% 6 months post-referral. Impact greater for participants 
referred to other funded services (48% reduction of inpatient admissions, 43% in A&E visits, 12 
months post-referral).  
 
Community: Small organisations without previous access to NHS funding were able to access it 
for the first time, which enhanced their provision and improved their sustainability. 
Programme 
name: 
Wellspring 
Wellbeing 
Programme24 
 
Location: 
Bristol, UK 
Aim: To connect, be active, take notice, 
keep learning and give.  
N= 128  
 
Age: 36-40 
 
Participants: Referred by GP. 
Date: 05-2012—04-2013  
 
Design and method:  
Pre/post; 
Interviews and questionnaires.  
 
Measurement: Hawthorne (2000) 
Friendship Scale and Wellspring 
Wellbeing Questionnaire to assess 
loneliness and social isolation. 
Person: Number of socially isolated (lonely) Friendship Scale measure decreased from 67.8% 
(n=59) to 33.4% (n=15) 3 months post-program. 
 
System: GP visits: 60% of participants reduced GP attendance rates 12 months post-
intervention, 26% no change, 14% increase. 
 
Community: Not assessed. 
  
Impact on the individual 
All 9 studies report positive impact on the individual social prescribing participant. 
Impact areas in addition to loneliness include health care service usage15,23–29 and social care 
service usage.34 Two studies report individuals expressing in interviews that they feel less 
lonely/more connected to others28,29 and 2 report changes in loneliness scores across the 
participant sample.22,23 The highest impact reported is 69% of individuals feeling less lonely 
(UCLA 3-question version).22  
Two of the studies examine the extent to which age might impact social prescribing 
programme implementation and loneliness.15,22 One of these studies reports greater 
improvements in loneliness for individuals under 60 years of age in comparison to those aged 
60 and above.22 One examines age as a contextual factor determining the pathway between a 
social prescribing programme and health care usage outcomes.15  
Impact on the health and care system(s) and Community  
Evaluation of the impact on health and care services is primarily focused on 
documenting numbers of GP visits, A&E visits, inpatient admissions, and outpatient 
admissions. Three studies report GP visit reduction ranging from 20%-68%.23,24,25 Two studies 
report an increase in GP and A&E visits following programme implementation.25,23 One study 
reports a 3% reduction in the number of contacts participants had with a social worker 
following programme implementation.25  
One study links measures of community belonging to system and individual health 
measures. It shows that being a member of a group (family, community, volunteering) 
positively predicts one’s sense of community belonging, which in turn predicts reduced 
loneliness and reduced health care usage.15 This study also reports that GPs view social 
prescribing as the best model to address loneliness and its negative impact on health.15  
  
The 9 studies diverge in how they assess impact on the community. One study reports 
greater participant awareness of available services and support.25 Two report organisations 
expanding their service capacity.28,27 One reports a greater sense of community 
connectedness.15 Five studies do not address programme impact on the community. 
Discussion 
 
Nine studies in this systematic review gauge the effects of social prescribing on 
loneliness. Overall, social prescribing models designed to address loneliness have been largely 
viewed as helpful by both participants and service providers. Participants report feeling less 
lonely and more connected to others. Participants feel good about their relationship with a link 
worker and appreciate the service delivery model. GPs, volunteers and delivery service 
members view social prescribing as a valid model to deliver comprehensive, people-centred 
and integrated care, and some GPs view social prescribing as the best possible approach to 
successfully address loneliness. The positive impact appears as a large percentage of reductions 
in GP, A&E, inpatient and outpatient services following programme implementation. 
However, the variability and paucity of evidence and lack of control group comparisons make 
it difficult to draw conclusions regarding the impact of the social prescribing model on 
loneliness in particular, or on public health in general. 
Quality of Impact Evidence  
Largely insufficient supporting evidence makes it difficult to quantify the impact of 
these programmes and interventions. The 9 studies primarily rely on a pre/post study design, 
lack control group comparisons and neglect to consider the potential influence of other 
conditions on the outcomes of interest. Study participants are typically selected via GP 
referrals, a selection that is not systematic or explained. In addition, several studies do not 
provide a clear definition or a measure of loneliness and often use social isolation and 
loneliness interchangeably.  
  
Despite programme participants reporting various health and social care needs, only 
one study examines social care outcomes.25 Because these initiatives are designed to address 
loneliness, the lack of attention to social care usage should be troubling. Without knowing the 
extent to which social service usage is affected, it is impossible to know whether social 
prescribing is meeting individual needs, changing referral rates, or yielding cost savings. We 
therefore have little to learn from these studies regarding the relationship between loneliness 
and social care usage, and even less regarding how the social prescribing person-centred 
approach might affect that relationship.  
Because social prescribing programmes are meant to deliver person-centred care, it is 
natural to be concerned with the impact of such programmes on individuals. Since person-
centred care is intended to account for social relationships and overall community 
connectedness, however, the impact of social prescribing on communities should also be 
considered. It is therefore surprising how few of the existing studies examine the relationship 
between social prescribing programmes and the communities in which they operate.  
The National Health Service (NHS) England has proposed a more systematic approach 
to capture community impact, which they assert should be done by assessing the capacity of 
community groups to manage social prescribing referrals.13,8 Given that community 
connectedness has also been linked to economic productivity, crime rates, civic behaviour, and 
empowerment, these are also community attributes wherein social prescribing programme 
impact could be measured.35  
Implications for research and/or practice 
A significant contribution of the social prescribing approach to person-centred care is 
that it allows services users and providers to co-design a model of care tailored to individual 
needs. The relationship participants and social prescribers develop over time is a potentially 
useful way for individuals to become less lonely, reconnect with their community, and improve 
  
their physical and mental wellbeing. The social prescribing model has the capacity to shift the 
focus from curative care to health promotion and disease prevention, and to thereby reduce 
pressure on health and care services.  
 Yet for social prescribing models to reach their full impact potential, the quality of 
evidence must improve. Studies should develop and file clear design protocols specifying 
pathways to impact and outcomes to be measured before programme implementation begins, 
accounting for potential intervening and contextual factors, and striving to achieve measures 
for comparative control groups. Employing good practices at both the implementation and 
evaluation stages will benefit participants in person-centred care systems as well as researchers 
who engage in the comparative study of public health.  
Conclusion  
 
Our study broadens current literature in two key respects. First, we are one of the first 
reviews to utilise NHS England and Drinkwater et al guidelines13,8 to examine evidence of 
social prescribing impact on the individual, the community, and the health/care system. 
Second, we are the only review to our knowledge to assess evidence of social prescribing 
specifically as it addresses the ‘loneliness epidemic’. Our findings show that that individuals 
and organisations view social prescribing initatives as useful and necessary to tackle loneliness. 
However, given the wide variation in social prescribing interventions and how/whether their 
impact is investigated, it is difficult to draw definite conclusions regarding the effectiveness of 
these initiatives on individuals, communities, and health/care systems in general.  
Similar to previous social prescribing research, our review highlights a fundamental 
need for consensus on what constitutes good impact evidence with respect to social 
prescribing.16,22,14,8 We demonstrate a gap between social prescribing design and social 
prescribing evaluation, and illuminate a lack of impact assessment in relation to social care.  
We also note a lack of consensus on what the impact of a person-centred approach such as 
  
social prescribing should be. Social prescribing is presented as a person-centred, holistic, 
integrated approach to addressing individual needs, meaning impact on the whole person, 
including social service usage, should be studied.  
Futhermore, we note a need for methodological and conceptutal clarity in relation to 
loneliness and related concepts such as social isolation. Being able to distinquish between these 
related phenomena is an essential first step for mapping out needs and services required to help 
lonely individuals, who are likely to feel alone even in a crowd. Improved impact evidence is 
needed to know best how to reach lonely individuals and address complex health and social 
needs that emerge as a result of loneliness. In particular, we note the need to study links 
between an individual’s level of loneliness and one’s health and social care usage, as well as 
the impact of these individual attributes on one’s wider community.  
We are compelled to  point out that the COVID-19 pandemic has changed both the way 
person-centred care such as social prescribing is and can be delivered, and the ways in which 
such programmes fit into the larger health picture. In  particular, much social prescribing in the 
UK is now being delivered via digital tablet, telephone, and email, with link workers 
connecting participants to social outlets virtually, helping to coordinate prescription delivery, 
and providing ways for people to connect to their communities while observing pandemic-
related restrictions.36  Importantly, social prescribing has also reportedly eased much of the 
burden GPs expected to encounter during pandemic management, as GPs have been able to 
refer patients to social prescribing services based on  telephone consultations, without causing 
anyone to physically attend a GP appointment.37  It thus appears that social prescribing is filling 
the role it was originally intended to have. Systematic and rigorous evaluations to this effect 
are long overdue. 
Limitations  
 
  
Our review includes the most recently available evidence on social prescribing. All of 
the studies were conducted from 2014-2019 in the UK. Although our search was not limited 
geographically or to this date range, our findings suggest that the ‘social prescribing’ 
nomenclature is not utilised regularly outside the UK, Canada, and a few select places, and/or 
that social prescribing programmes are rarely assessed in terms of their impact on loneliness. 
Our work also demonstrates that the UK initiative to deliver person-centred care via social 
prescribing can only be based on evidence from the past five years. 
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